Mather Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.2K | Buy |
+58
| New | +$16.7K | ﹤0.01% | 1334 |
|
|
2025
Q4 | – | Sell |
-58
| Closed | -$16.3K | – | 761 |
|
|
2025
Q3 | $16.3K | Buy |
+58
| New | +$15.8K | ﹤0.01% | 1162 |
|
|
2025
Q2 | – | Sell |
-311
| Closed | -$75.7K | – | 732 |
|
|
2025
Q1 | $75.7K | Sell |
311
-150
| -33% | -$45.1K | ﹤0.01% | 820 |
|
|
2024
Q4 | $151K | Buy |
461
+292
| +173% | +$99.1K | ﹤0.01% | 650 |
|
|
2024
Q3 | $56.5K | Sell |
169
-191
| -53% | -$60.7K | ﹤0.01% | 856 |
|
|
2024
Q2 | $125K | Buy |
360
+100
| +38% | +$29.1K | ﹤0.01% | 745 |
|
|
2024
Q1 | $84K | Buy |
+260
| New | +$85.5K | ﹤0.01% | 754 |
|
|
2023
Q2 | – | Sell |
-520
| Closed | -$249K | – | 622 |
|
|
2023
Q1 | $249K | Buy |
520
+3
| +0.6% | +$1.4K | ﹤0.01% | 436 |
|
|
2022
Q4 | $217K | Buy |
+517
| New | +$209K | ﹤0.01% | 449 |
|
|
2022
Q3 | – | Sell |
-421
| Closed | -$208K | – | 471 |
|
|
2022
Q2 | $208K | Buy |
421
+44
| +12% | +$22.9K | ﹤0.01% | 361 |
|
|
2022
Q1 | $212K | Buy |
377
+24
| +7% | +$14.5K | ﹤0.01% | 419 |
|
|
2021
Q4 | $267K | Sell |
353
-15
| -4% | -$11.2K | 0.01% | 317 |
|
|
2021
Q3 | $275K | Sell |
368
-20
| -5% | -$15K | 0.01% | 236 |
|
|
2021
Q2 | $250K | Sell |
388
-5
| -1% | -$3.04K | 0.01% | 239 |
|
|
2021
Q1 | $224K | Buy |
393
+1
| +0.3% | +$592 | 0.01% | 241 |
|
|
2020
Q4 | $229K | Buy |
392
+3
| +0.8% | +$1.71K | 0.01% | 220 |
|
|
2020
Q3 | $201K | Buy |
+389
| New | +$197K | 0.01% | 232 |
|
Other funds holding BIO
VCM
VPM
AI
